Edge Wealth Management LLC Eli Lilly & CO Transaction History

Edge Wealth Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 14, 2022	SELL	$234.69 - $291.66 $14,550 - $18,082	-62 Closed	0 $0
Q1 2021 Apr 09, 2021	BUY	$164.32 - $212.72 $5,258 - $6,807	32 Added 106.67%	62 $12,000
Q4 2020 Jan 19, 2021	SELL	$130.46 - $172.63 $65,230 - $86,315	-500 Reduced 94.34%	30 $5,000
Q1 2020 Apr 20, 2020	SELL	$119.05 - $147.35 $10,595 - $13,114	-89 Reduced 14.38%	530 $74,000
Q4 2019 Jan 29, 2020	BUY	$106.92 - $132.43 $9,515 - $11,786	89 Added 16.79%	619 $81,000
Q4 2017 Jan 18, 2018	SELL	$81.94 - $87.89 $2,458 - $2,636	-30 Reduced 5.36%	530 $44,000
Q3 2017 Oct 19, 2017	BUY	$77.07 - $85.54 $43,159 - $47,902	560	560 $48,000

4,121

740M

8.26M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $835B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Edge Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Edge Wealth Management LLC with notifications on news.